News | News By Subject | News by Disease News By Date | Search News

Human papilloma virus (HPV) News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Genticel's HPV Candidate Did Not Meet Primary Endpoint in Phase II Study     1/27/2016
bluebird bio (BLUE) Plans Annual Hiring of 100+ for the Next Few Years     11/6/2015
Kite Pharma (KITE), bluebird bio (BLUE) Ink Deal to Zero In on HPV-Linked Cancer     6/22/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
San Diego Startup, Hera Therapeutics, Unveils Drug For Viral Infections Tied To Cervical Cancer     8/25/2014
Merck & Co., Inc. (MRK)'s Gardasil HPV Vaccine Doesn't Increase Blood Clot Risk     7/9/2014
Merck & Co., Inc. (MRK), GlaxoSmithKline (GSK) Reduce HPV Vaccine Prices by 95 Pct. in Poorest Regions     5/9/2013
Merck & Co., Inc. (MRK)'s HPV Vaccine Gardasil Shown Safe in Kaiser Permanente Study     10/2/2012
Studies Show GlaxoSmithKline (GSK)'s HPV Vaccine Fights Cervical Cancer     11/9/2011
Merck & Co., Inc. (MRK)'s Gardasil Vaccine Wins U.S. Panel Backing for Routine Use in Boys     10/27/2011
SANE Vax, Inc. Reports Human Papillomavirus (HPV) DNA Contamination in Gardasil(TM) to FDA: Requests Public Safety Investigation     9/6/2011
Merck & Co., Inc. (MRK)'s GARDASIL(R) Approved by Health Canada for Males to Prevent Genital Warts     2/24/2010
Advaxis, Inc. Phase II Clinical Trial HOLD Lifted     1/6/2009

News from Around the Web
63 Japanese Women Sue the Government, GlaxoSmithKline (GSK) and Merck & Co. (MRK) Over HPV Vaccines     10/24/2016
Outcomes For Girls Without HPV Vaccination In Japan, Osaka University Study     9/13/2016
Should Boys Get The HPV Vaccine?     9/13/2016
HPV Rate In Teen Girls Drops By More Than 60 Percent     2/22/2016
Mushroom Extract, AHCC, Helpful In Treating HPV, University of Texas Health Science Center Research Shows     10/30/2014
69 Percent Of Americans Infected With HPV, NYU Langone Medical Center Study Suggests     5/27/2014
Foreskin May Be Reservoir for HPV, Innsbruck Medical University Study     5/18/2011
Protein Inhibitor May Bring a Topical Treatment for HPV, Tufts University Study     4/26/2011
Half of Men May Have HPV, H. Lee Moffitt Cancer Center & Research Institute Study Shows     3/1/2011
HPV Vaccine: Cost-effective Way to Prevent Anal Cancer, Harvard School of Public Health Study     11/3/2010
An HPV Vaccine Cheap Enough for the Developing World? Could Be According to Duke University Researchers     7/30/2010
HPV Vaccine For Boys Available     6/24/2010
Protection from GlaxoSmithKline (GSK)'s HPV Vaccine Lasts Longer than Six Years, University of New Mexico Study     12/3/2009
Circumcision Cuts Rates of Herpes, HPV, Johns Hopkins University And Study     3/26/2009
Researchers Report Breakthrough In Human Papillomavirus Research, University of Alabama at Birmingham Study     2/26/2009

Press Releases
Masonic Cancer Center Release: Immune Response To HPV Impacts Head And Neck Cancer Prognosis     12/8/2016
Inovio Pharma (INO)’s Cancer Immunotherapy (INO-3112) Generates T Cell Immune Responses In Tumor Tissue And Peripheral Blood In Patients With HPV-Associated Head And Neck Cancer     11/14/2016
ARTES Biotechnology And BioSun Announce Co-Development For HPV Vaccine     11/4/2016
GlaxoSmithKline (GSK) Yanks HPV Vaccine From U.S. Market     10/25/2016
PharmaJet And Vaccibody Collaborate On HPV Vaccine Development     10/25/2016
Inovio Pharma (INO) Shares Crash as the FDA Places Hold on Its Phase III HPV Program     10/24/2016
Cincinnati Children's Hospital Medical Center Release: Study Suggests HPV Vaccine Could Have Substantial Impact On Rates Of Cervical Cancers     9/21/2016
Becton, Dickinson and Company (BDX) Submits Pre-Market Approval Application to FDA for BD Onclarity HPV Test     9/6/2016
Novan To Present Anti-Viral Data For Nitric Oxide Product Candidate SB206     5/10/2016
PDS Biotechnology Corporation Reports Positive Phase 1 Study Results For PDS0101 Immunotherapy For HPV-Related Cancers     4/13/2016
Albert Einstein College of Medicine Release: Study Examines Link Between HPV And Risk Of Head And Neck Cancers     1/22/2016
oncgnostics GmbH Release: Safe Diagnostics For Women Tested HPV-Positive     1/20/2016
Janssen Announces Collaboration With Bavarian Nordic (BAVA.CO) To Develop Vaccine For Chronic Human Papillomavirus (HPV) Infections     12/21/2015
Hologic (HOLX) Release: New Modeling Analysis Shows Screening For Cervical Cancer With Pap+HPV Together Could Provide Better Clinical And Economic Outcomes Than Screening With HPV Alone     11/12/2015
Genticel Announces First Patient Treated In U.S. Phase 1 Clinical Trial Of GTL001, Company's Therapeutic Vaccine Candidate Against HPV 16/18 Infections     10/29/2015

//-->